Where can treat recurrent lung cancer

summary

What my uncle got is small cell lung cancer. When it was released, it was early and the treatment was relatively timely. Some time ago, when he was reexamined, he found a recurrence. So I will explain to you where to treat recurrent lung cancer.

Where can treat recurrent lung cancer

First of all, lung cancer is one of the most common malignant tumors, in which small cell lung cancer (SCLC) accounts for about 13%. Due to the biological characteristics of SCLC, such as high invasion, high recurrence and rapid growth, it is difficult to deal with this kind of tumor which is sensitive to initial treatment but difficult to relapse.

Secondly, the effective rate of second-line chemotherapy for recurrent SCLC mainly depends on the time from remission to tumor progression after first-line treatment, which is generally divided into two categories: refractory or drug-resistant type with no response to first-line treatment or remission time less than 3 months; sensitive type with remission time more than 3 months. The purpose of the first-line treatment is to kill the chemotherapy sensitive cells. Early progress indicates that there are fewer chemotherapy sensitive tumor cells and more drug-resistant cells. The effective rate is often less than 10%. The survival time is usually several weeks after the second-line treatment.

Finally, if the time from remission to progression is long, the effective rate is likely to increase with the extension of the time from remission to progression. At present, the NCCN guidelines also follow the above classification principles in the treatment of recurrent SCLC. Topotecan is recommended for sensitive recurrence based on class I evidence, but the first-line treatment is still recommended when the remission time is more than 6 months. In this paper, the current situation and progress of cytotoxic drugs in the second and third line treatment of recurrent SCLC, as well as the research of targeted drugs are summarized and summarized.

matters needing attention

Patients with lung cancer chemotherapy diet should be light, avoid fat, indigestible food and fried food. Eat more fresh vegetables and fruits, eat less and have more meals, have reasonable food collocation, have diversified recipes and have a balanced diet. During the interval of radiotherapy and chemotherapy, attention should be paid to avoid fatigue, rest, regular work and rest, and infection.